About us.
2012
The Patankar group (University of Wisconsin Medical School) suggests an expanded role for cytotoxic immune cells in female pelvic diseases. At the same time they point out that current technology lacks the sensitivity needed to fully understand this role.
2015
PNPResearch Corporation is founded based on a novel
approach to the sensitivity problem.
2015/2016
A grant from the Massachusetts Life Science Center
funds proof of principle for the new technology. A
manual dark field microscope is combined with gold
nanoparticles achieving near single molecule detection
sensitivity.
2016/2017
A combination of artificial intelligence and algorithms
inspired by astronomy observations replace the human
eye.
2018
A fully automated analysis system is developed which
allows the researcher to insert the blood sample, walk
away, and come back for the results.
2019
The new high sensitivity system allows better
understanding of the role of cytotoxic immune cells in
patients with serous invasive ovarian cancer (Optical
Society of America publication).
A grant from the US military funds pioneering work on
the role of the immune system in Traumatic Brain
Injury.
2020/2021
Research laboratories were shut down to prevent the
spread of COVID-19.
We focused on the analysis of archived data and
published results concerning the role of the immune
system in ovarian cancer and in Traumatic Brain Injury.
2022
First data on the value of the technology in ovarian
cancer therapy monitoring are published.
2023
The data on therapy monitoring in ovarian cancer result
in a grant from the Wisconsin Alumni Research
Foundation (WARF), funding a multicenter longitudinal
clinical study, under the leadership of Manish Patankar.
2024
Sample collection under the WARF grant continues.
2025
… stay tuned …